Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020
Insights
Two coronavirus disease patients experienced presumed thrombotic stroke despite anticoagulation for atrial fibrillation. One patient tested positive for antiphospholipid antibodies, indicating severe stroke risks associated with COVID-19.
Area of Science:
- Neurology
- Infectious Diseases
- Cardiology
Background:
- Atrial fibrillation necessitates anticoagulation for stroke prevention.
- Coronavirus disease (COVID-19) has been associated with various neurological complications.
- Antiphospholipid antibodies are linked to thrombotic events.
Observation:
- Two cases of presumed thrombotic stroke in COVID-19 patients in France were observed.
- Both patients were undergoing anticoagulation therapy for atrial fibrillation.
- One patient presented with positive antiphospholipid antibodies.
Findings:
- Thrombotic stroke can occur in COVID-19 patients even with anticoagulation.
- The presence of antiphospholipid antibodies may increase stroke risk in this context.
- These cases suggest a complex interplay between COVID-19, anticoagulation, and thrombosis.
Implications:
- COVID-19 poses unique cerebrovascular risks, including stroke.
- Careful consideration of thrombotic risk is needed for COVID-19 patients with atrial fibrillation.
- Further research is warranted to understand and manage COVID-19-associated stroke.
Abstract:
We describe 2 cases in coronavirus disease patients in France involving presumed thrombotic stroke that occurred during ongoing anticoagulation treatment for atrial fibrillation stroke prophylaxis; 1 patient had positive antiphospholipid antibodies. These cases highlight the severe and unique consequences of coronavirus disease-associated stroke.
Related Concept Videos
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction


